IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Iovance Biotherapeutics Inc

CUSIP: SBF0DMK71 | 1 institutional holders

Quarters

Q1 2023Q2 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2023

Metropolitan Life Insurance Co8,165
0.0% of portfolio›$49.9K
StyleTurnoverLocationFiled
Metropolitan Life Insurance Co
8,165$49.9K0.0%ETFVery LowNew York, NY2023-05-15